6 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
3 Things to Know if Chloroquine Wins the COVID-19 Treatment Race https://www.fool.com/investing/2020/03/27/3-things-to-know-if-chloroquine-wins-the-covid-19.aspx?source=iedfolrf0000001 Mar 27, 2020 - An old malaria drug may unseat newer investigational coronavirus treatments -- if data is confirmed.
4 Reasons Drug Stocks Are a Buy Right Now https://www.fool.com/investing/2020/03/30/4-reasons-drug-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001 Mar 30, 2020 - Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
Charges dropped for topless protesters at Sanders NV rally https://www.startribune.com/charges-dropped-for-topless-protesters-at-sanders-nv-rally/569178702/ Mar 27, 2020 - Criminal charges have been dropped in Nevada against three topless protesters who were arrested at a rally for Democratic presidential hopeful Bernie Sanders in Carson City in February.
NVS vs. NVO: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/849177/nvs-vs-nvo-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-849177 Apr 01, 2020 - NVS vs. NVO: Which Stock Is the Better Value Option?
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181 Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
Lilly's Taltz Gets FDA Nod for Plaque Psoriasis in Children http://www.zacks.com/stock/news/847430/lillys-taltz-gets-fda-nod-for-plaque-psoriasis-in-children?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-847430 Mar 31, 2020 - The FDA approves Eli Lilly's (LLY) sBLA for Taltz injection to treat pediatric patients with moderate to severe plaque psoriasis. Stock up.

Pages: 1

Page 1